Connect with us

Business

Win for Aussie workers as Coles signs ‘groundbreaking’ deal – Yahoo Finance Australia

The new charter of standards will protect workers in Coles’ supply chain as well as Aussies driving on the road.

Published

on

post featured image

* Findings presented at SABCS from largest intrinsic subtype analysis show Kisqali is unique among CDK4/6 inhibitors, delivers consistent efficacy across main HR+/HER2- intrinsic subtypes1 * Benefit seen even in patients with the endocrine-resistant HER2-enriched subtype, who face poor prognosis with endocrine therapy alone, reinforces Kisqali as first line treatment choice for all patients2 * Data presented at SABCS also show Kisqali more selectively inhibits CDK4, the active target in breast cancer…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending